|
1
|
Smith A, Teknos TN and Pan Q: Epithelial
to mesenchymal transition in head and neck squamous cell carcinoma.
Oral Oncol. 49:287–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hennessy BT, Gonzalez-Angulo AM,
Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J,
Sahin A, Agarwal R, Joy C, et al: Characterization of a naturally
occurring breast cancer subset enriched in
epithelial-to-mesenchymal transition and stem cell characteristics.
Cancer Res. 69:4116–4124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chung S, Yao J, Suyama K, Bajaj S, Qian X,
Loudig OD, Eugenin EA, Phillips GR and Hazan RB: N-cadherin
regulates mammary tumor cell migration through Akt3 suppression.
Oncogene. 32:422–430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li G, Satyamoorthy K and Herlyn M:
N-cadherin-mediated intercellular interactions promote survival and
migration of melanoma cells. Cancer Res. 61:3819–3825.
2001.PubMed/NCBI
|
|
6
|
Miao Y, Li AL, Wang L, Fan CF, Zhang XP,
Xu HT, Yang LH, Liu Y and Wang EH: Overexpression of NEDD9 is
associated with altered expression of E-cadherin, β-catenin and
N-cadherin and predictive of poor prognosis in non-small cell lung
cancer. Pathol Oncol Res. 19:281–286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mao J, Fan S, Ma W, Fan P, Wang B, Zhang
J, Wang H, Tang B, Zhang Q, Yu X, et al: Roles of Wnt/β-catenin
signaling in the gastric cancer stem cells proliferation and
salinomycin treatment. Cell Death Dis. 5:e10392014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tothill RW, Tinker AV, George J, Brown R,
Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro
B, et al: Novel molecular subtypes of serous and endometrioid
ovarian cancer linked to clinical outcome. Clin Cancer Res.
14:5198–5208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tulalamba W and Janvilisri T:
Nasopharyngeal carcinoma signaling pathway: An update on molecular
biomarkers. Int J Cell Biol. 2012:5946812012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tao Q and Chan AT: Nasopharyngeal
carcinoma: Molecular pathogenesis and therapeutic developments.
Expert Rev Mol Med. 9:1–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian Y, Tian Y, Zhang W, Wei F, Yang J,
Luo X, Zhou T, Hou B, Qian S, Deng X, et al: Junctional adhesion
molecule-A, an epithelial-mesenchymal transition inducer,
correlates with metastasis and poor prognosis in human
nasopharyngeal cancer. Carcinogenesis. 36:41–48. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM, Haller DG and Morrow M: AJCC cancer staging manual.
Springer Science & Business Media; 2002, View Article : Google Scholar
|
|
14
|
Li G, Liu Y, Liu C, Su Z, Ren S, Wang Y,
Deng T, Huang D, Tian Y and Qiu Y: Genome-wide analyses of long
noncoding RNA expression profiles correlated with radioresistance
in nasopharyngeal carcinoma via next-generation deep sequencing.
BMC Cancer. 16:7192016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hui L, Zhang S, Dong X, Tian D, Cui Z and
Qiu X: Prognostic significance of twist and N-cadherin expression
in NSCLC. PLoS One. 8:e621712013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nollet F, Kools P and van Roy F:
Phylogenetic analysis of the cadherin superfamily allows
identification of six major subfamilies besides several solitary
members. J Mol Biol. 299:551–572. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng Z, Pan J, Chu B, Wong YC, Cheung AL
and Tsao SW: Downregulation and abnormal expression of E-cadherin
and beta-catenin in nasopharyngeal carcinoma: Close association
with advanced disease stage and lymph node metastasis. Hum Pathol.
30:458–466. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guilford P: E-cadherin downregulation in
cancer: Fuel on the fire? Mol Med Today. 5:172–177. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He X, Chen Z, Jia M and Zhao X:
Downregulated E-cadherin expression indicates worse prognosis in
Asian patients with colorectal cancer: Evidence from meta-analysis.
PloS One. 8:e708582013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang Y, Liang X, Jiang W, Li J, Xu J and
Cai X: Cyclin b1 suppresses colorectal cancer invasion and
metastasis by regulating e-cadherin. PloS One. 10:e01268752015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Canel M, Serrels A, Frame MC and Brunton
VG: E-cadherin-integrin crosstalk in cancer invasion and
metastasis. J Cell Sci. 126:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo WR, Wu AB, Fang WY, Li SY and Yao KT:
Nuclear expression of N-cadherin correlates with poor prognosis of
nasopharyngeal carcinoma. Histopathology. 61:237–246. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nagi C, Guttman M, Jaffer S, Qiao R, Keren
R, Triana A, Li M, Godbold J, Bleiweiss IJ and Hazan RB: N-cadherin
expression in breast cancer: Correlation with an aggressive
histologic variant-invasive micropapillary carcinoma. Breast Cancer
Res Treat. 94:225–235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Liu G, Kang Y, Dong Z, Qian Q and
Ma X: N-cadherin expression is associated with acquisition of EMT
phenotype and with enhanced invasion in erlotinib-resistant lung
cancer cell lines. PloS One. 8:e576922013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Di Domenico M, Pierantoni GM, Feola A,
Esposito F, Laino L, DE Rosa A, Rullo R, Mazzotta M, Martano M,
Sanguedolce F, et al: Prognostic significance of N-cadherin
expression in oral squamous cell carcinoma. Anticancer Res.
31:4211–4218. 2011.PubMed/NCBI
|
|
26
|
Marie PJ: Role of N-cadherin in bone
formation. J Cell Physiol. 190:297–305. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alaee M, Danesh G and Pasdar M:
Plakoglobin Reduces the in vitro Growth, Migration and Invasion of
Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS
One. 11:e01543232006. View Article : Google Scholar
|
|
28
|
Musumeci G, Magro G, Cardile V, Coco M,
Marzagalli R, Castrogiovanni P, Imbesi R, Graziano AC, Barone F, Di
Rosa M, et al: Characterization of matrix metalloproteinase-2 and
−9, ADAM-10 and N-cadherin expression in human glioblastoma
multiforme. Cell Tissue Res. 362:45–60. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tani T, Laitinen L, Kangas L, Lehto VP and
Virtanen I: Expression of E- and N-cadherin in renal cell
carcinomas, in renal cell carcinoma cell lines in vitro and in
their xenografts. Int J Cancer. 64:407–414. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nagafuchi A and Takeichi M: Cell binding
function of E-cadherin is regulated by the cytoplasmic domain. EMBO
J. 7:36791988.PubMed/NCBI
|
|
31
|
Rappl A, Piontek G and Schlegel J:
EGFR-dependent migration of glial cells is mediated by
reorganisation of N-cadherin. J Cell Sci. 121:4089–4097. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Méndez-Samperio P, Pérez A and Rivera L:
Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced
activation of PI3K/Akt and NF-kB signaling pathways regulates
expression of CXCL10 in epithelial cells. Cell Immunol. 256:12–18.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
